Actively Recruiting
Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.
Led by Fundacin Biomedica Galicia Sur · Updated on 2024-02-28
3788
Participants Needed
1
Research Sites
678 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Colorectal cancer (CRC) screening programs have been implemented to reduce the burden of the disease. When an advanced colonic lesions is detected, it is recommended to perform endoscopic surveillance with different intervals between explorations. Although the reduction in CRC incidence, endoscopic surveillance is producing a considerable increase in the number of colonoscopies. However, participation in CRC screening programs based on the fecal immunochemical test (FIT) could be a non inferior alternative to endoscopic surveillance. Based on this hypothesis, the research group have designed a randomized clinical trial within the population CRC screening programs to compare FIT surveillance to endoscopic surveillance in patients with advanced lesions resected.
CONDITIONS
Official Title
Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 50 to 65 years
- At least one advanced adenoma (tubulovillous or villous histology, high grade dysplasia or 210mm), and/or at least three non-advanced adenomas completely removed within CRC screening programs
You will not qualify if you...
- Personal history of colorectal cancer
- Colonic lesion 10mm or larger removed without histological diagnosis
- More than 10 adenomas found in baseline colonoscopy
- Serrated polyposis syndrome
- Two or more first-degree relatives with colorectal cancer
- Hereditary predisposition to colorectal cancer
- Serious illnesses with life expectancy under 5 years
- Colonoscopy with incomplete mucosal examination
- Incomplete removal of baseline lesions
- Not agreeing to participate after informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Complexo Hospitalario Universitario de Ourense
Ourense, Spain, 32002
Actively Recruiting
Research Team
J
Joaquín Cubiella, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here